|
Jan 20
|
These 2 Phenomenal Growth Stocks Can Make You Richer in 2024
|
|
Jan 20
|
3 High-Flying Stocks That Could Soar Even More in 2024
|
|
Jan 18
|
Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update
|
|
Jan 17
|
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors
|
|
Jan 17
|
Vertex (VRTX), CRSP's Casgevy Gets FDA Nod for Thalassemia
|
|
Jan 17
|
Vertex to Announce Fourth Quarter and Full Year 2023 Financial Results on February 5
|
|
Jan 17
|
The Best Stock to Invest $1,000 in Right Now
|
|
Jan 16
|
Crispr Wins Its Second Gene-Editing Approval In Another Boost To Vertex Stock
|
|
Jan 16
|
UPDATE 2-US FDA approves Vertex/CRISPR gene therapy for an inherited blood disorder
|
|
Jan 16
|
Vertex Announces US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Transfusion-Dependent Beta Thalassemia
|
|
Jan 15
|
Down 88%, Could Editas Medicine Be a Good Investment Now?
|
|
Jan 14
|
What Does It Mean for Investors if CRISPR Therapeutics Gets Bought Out in 2024?
|
|
Jan 14
|
My 3 Highest-Conviction Growth Stocks to Buy in 2024
|
|
Jan 14
|
3 Growth Stocks to Buy That Could Be Massive Long-Term Winners
|
|
Jan 13
|
3 Unstoppable Stocks to Buy in 2024
|
|
Jan 10
|
2 Red Flags for Bluebird Bio Stock
|
|
Jan 10
|
These 3 Stocks Have Beaten the S&P Average Return for Years and Are Likely to Continue That Trend
|
|
Jan 9
|
Here's How Much You'd Have If You Invested $1000 in Vertex Pharmaceuticals a Decade Ago
|
|
Jan 9
|
Vertex Pharmaceuticals (VRTX) Ascends While Market Falls: Some Facts to Note
|
|
Jan 9
|
What Makes Vertex Pharmaceuticals (VRTX) a Strong Momentum Stock: Buy Now?
|